                         SEQUENCE LISTING

<110>  University of Utah Research Foundation
 
<120>  METHODS AND COMPOSITIONS OF SUBSTITUTED 
       5H-[1,2,5]OXADIAZOLO[3',4':5,6]PYRAZINO[2,3-B]INDOLE ANALOGS AS 
       INHIBITORS OF BETA-CATENIN/T-CELL FACTOR PROTEIN-PROTEIN 
       INTERACTIONS

<130>  21101.0309P1

<150>  62/163,346
<151>  2015-05-18

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1

Gly Gly Gly Asp Asp Leu Gly Ala Asn Asp Glu Leu Ile Ser Phe Lys 
1               5                   10                  15      


Asp Glu Gly Glu Gln Glu Glu Lys Ser Ser Glu Asn Ser Ser Ala Glu 
            20                  25                  30          


Arg Asp Leu Ala Asp Val Lys Ser Ser Leu Val Asn Glu Lys 
        35                  40                  45      


<210>  2
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Gly Gly Gly Asp Asp Leu Gly Ala Asn Asp Glu Leu Ile Ser Phe Lys 
1               5                   10                  15      


Asp Glu Gly Glu Gln Glu Glu Lys Ser Ser Glu Asn Ser Ser Ala Glu 
            20                  25                  30          


Arg Asp Leu Ala Asp Val Lys Ser Ser Leu Val Asn Glu Lys 
        35                  40                  45      


<210>  3
<211>  55
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3

Asp Thr Asp Pro Thr Ala Pro Pro Tyr Asp Ser Leu Leu Val Phe Asp 
1               5                   10                  15      


Tyr Glu Gly Ser Gly Ser Glu Ala Ala Ser Leu Ser Ser Leu Asn Ser 
            20                  25                  30          


Ser Glu Ser Asp Lys Asp Gln Asp Tyr Asp Tyr Leu Asn Glu Trp Gly 
        35                  40                  45              


Asn Arg Phe Lys Lys Leu Ala 
    50                  55  


<210>  4
<211>  43
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4

Gln Arg Val Gln Val Leu Pro Asp Ala Asp Thr Leu Leu His Phe Ala 
1               5                   10                  15      


Thr Glu Ser Thr Pro Asp Gly Phe Ser Cys Ser Ser Ser Leu Ser Ala 
            20                  25                  30          


Leu Ser Leu Asp Glu Pro Phe Ile Gln Lys Asp 
        35                  40              


